Telik's Drug Problem

Telik's Drug Problem

There are 1 comment on the Forbes.com story from Jun 5, 2007, titled Telik's Drug Problem. In it, Forbes.com reports that:

“Anticipating significant shareholder backlash and harsh challenge to management credibility, we believe Telik will drown in negative publicity pending FDA review of Telcyta clinical data”

Telik shares nosedived on Tuesday after the company announced that the U.S. Food and Drug Administration pulled the plug on human trials for Telcyta, its ovarian cancer treatment. via Forbes.com

Join the discussion below, or Read more at Forbes.com.

“ONLY THE BEST”

Since: May 07

CRANSTON [ PROV ] RHODE ISLAND

#1 Jun 5, 2007
IT MUST TO TRUE, NO WAY WILL THEY DO THAT TO ANY COMPANY, BUT IF IT HAS ALL GOOD AND I NEEDED I WOULD USE IT OR GET IT SOME HOW

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Telik Discussions

Title Updated Last By Comments
News Cancer Drug Fails Test, and the Company's Stock... (Dec '06) Dec '06 gdpawel 1
News Telik's US shares dive on drug admission (Dec '06) Dec '06 Dmitriy 1
More from around the web